LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 1476 | 3868 | 3694 | 1.0471 | 1.0784 |
| SK-BR-3 | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 1476 | 3826 | 3694 | 1.0357 | 1.0595 |
| SK-BR-3 | JNK-9L | 0.04 | uM | LJP6 | 1 | K24 | 72 | hr | 1476 | 2250 | 3694 | 0.6091 | 0.3487 |
| SK-BR-3 | JNK-9L | 0.04 | uM | LJP6 | 2 | K24 | 72 | hr | 1476 | 2651 | 3694 | 0.7176 | 0.5296 |
| SK-BR-3 | JNK-9L | 0.04 | uM | LJP6 | 3 | K24 | 72 | hr | 1476 | 2925 | 3694 | 0.7918 | 0.6532 |
| SK-BR-3 | JW-7-24-1 | 0.04 | uM | LJP6 | 1 | B24 | 72 | hr | 1476 | 2669 | 3694 | 0.7225 | 0.5377 |
| SK-BR-3 | JW-7-24-1 | 0.04 | uM | LJP6 | 2 | B24 | 72 | hr | 1476 | 2983 | 3694 | 0.8075 | 0.6793 |
| SK-BR-3 | JW-7-24-1 | 0.04 | uM | LJP6 | 3 | B24 | 72 | hr | 1476 | 2722 | 3694 | 0.7369 | 0.5616 |
| SK-BR-3 | Lapatinib | 0.04 | uM | LJP6 | 1 | M24 | 72 | hr | 1476 | 1370 | 3694 | 0.3709 | -0.0481 |
| SK-BR-3 | Lapatinib | 0.04 | uM | LJP6 | 2 | M24 | 72 | hr | 1476 | 1708 | 3694 | 0.4624 | 0.1043 |
| SK-BR-3 | Lapatinib | 0.04 | uM | LJP6 | 3 | M24 | 72 | hr | 1476 | 1514 | 3694 | 0.4099 | 0.0168 |
| SK-BR-3 | LDN-193189 | 0.04 | uM | LJP5 | 1 | G06 | 72 | hr | 1476 | 3683 | 3694 | 0.9970 | 0.9950 |
| SK-BR-3 | LDN-193189 | 0.04 | uM | LJP5 | 2 | G06 | 72 | hr | 1476 | 3890 | 3694 | 1.0530 | 1.0884 |
| SK-BR-3 | LDN-193189 | 0.04 | uM | LJP5 | 3 | G06 | 72 | hr | 1476 | 4259 | 3694 | 1.1529 | 1.2548 |
| SK-BR-3 | Linifanib | 0.04 | uM | LJP6 | 1 | J12 | 72 | hr | 1476 | 3579 | 3694 | 0.9689 | 0.9481 |
| SK-BR-3 | Linifanib | 0.04 | uM | LJP6 | 2 | J12 | 72 | hr | 1476 | 4207 | 3694 | 1.1389 | 1.2313 |
| SK-BR-3 | Linifanib | 0.04 | uM | LJP6 | 3 | J12 | 72 | hr | 1476 | 4324 | 3694 | 1.1705 | 1.2841 |
| SK-BR-3 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1476 | 2556 | 3694 | 0.6919 | 0.4868 |
| SK-BR-3 | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 1476 | 2656 | 3694 | 0.7190 | 0.5319 |
| SK-BR-3 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1476 | 2584 | 3694 | 0.6995 | 0.4994 |
| SK-BR-3 | Mitoxantrone | 0.04 | uM | LJP5 | 1 | C24 | 72 | hr | 1476 | 1642 | 3694 | 0.4445 | 0.0745 |
| SK-BR-3 | Mitoxantrone | 0.04 | uM | LJP5 | 2 | C24 | 72 | hr | 1476 | 1473 | 3694 | 0.3988 | -0.0017 |
| SK-BR-3 | Mitoxantrone | 0.04 | uM | LJP5 | 3 | C24 | 72 | hr | 1476 | 1366 | 3694 | 0.3698 | -0.0499 |
| SK-BR-3 | Mitoxantrone | 0.04 | uM | LJP6 | 1 | C24 | 72 | hr | 1476 | 1333 | 3694 | 0.3609 | -0.0648 |
| SK-BR-3 | Mitoxantrone | 0.04 | uM | LJP6 | 2 | C24 | 72 | hr | 1476 | 1623 | 3694 | 0.4394 | 0.0660 |